Medtronic (NYSE:MDT) today launched its newest drug-eluting coronary stent, Onyx Frontier. The Fridley, Minnesota-based company designed the Onyx Frontier drug-eluting stent (DES) to build upon its Resolute Onyx DES. It uses the same stent platform as the Resolute Onyx and has an enhanced delivery system to increase acute performance in … [Read more...] about Medtronic launches Onyx Frontier drug-eluting stent
Imagin Medical acquires Trod Medical’s enCage Coil precision ablation system
Imagin Medical this week announced it has acquired Trod Medical's enCage Coil precision ablation system. The company will acquire the enCage Coil for $2.5 million, which will be paid over time once certain developmental milestones are met. There will be an initial payment on the closing of $350,000 and $150,000 of Imagin shares. Of the initial … [Read more...] about Imagin Medical acquires Trod Medical’s enCage Coil precision ablation system
Endo Tools Therapeutics announces first commercial cases of Endomina endoscopic suture device
Endo Tools Therapeutics (ETT) this week announced the first U.S. commercial cases using its Endomina system. Gosselies, Belgium-based ETT designed Endomina for endoscopic placement of sutures and approximation of soft tissue in the gastrointestinal tract. The first procedures were performed at Brigham and Women's Hospital in Boston, … [Read more...] about Endo Tools Therapeutics announces first commercial cases of Endomina endoscopic suture device
EndoQuest Robotics’ endoluminal surgical robot wins best application award in 2022 Surgical Robotic Challenge
EndoQuest Robotics today announced its Endoluminal Surgical (ELS) system won the best application award in the 2022 Surgical Robotic Challenge. The Surgical Robotic Challenge is an international competition for healthcare robotics groups to showcase new and innovative ideas across a range of surgical robot platforms. It is presented at the … [Read more...] about EndoQuest Robotics’ endoluminal surgical robot wins best application award in 2022 Surgical Robotic Challenge
BD initiates first-in-human trial of sirolimus drug-coated balloon
BD today announced it started enrollment in the first-in-human trial of a peripheral sirolimus drug-coated balloon (DCB). The Prevision trial is a prospective, multi-center, single-arm, non-randomized study that will evaluate the safety of BD's DCB in the treatment of peripheral arterial disease (PAD) in the femoropopliteal arteries. The company … [Read more...] about BD initiates first-in-human trial of sirolimus drug-coated balloon
The 24 best medical device innovations of 2022
The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products … [Read more...] about The 24 best medical device innovations of 2022
Boston Scientific acquires Obsidio and its gel embolic material
Boston Scientific (NYSE:BSX) today announced the acquisition of Obsidio and its blood vessel embolization material technology. The financial details of the deal were not disclosed. Obsidio develops gel embolic material (GEM) technology that is used for the embolization of blood vessels in the peripheral vasculature. It is a semi-solid, gel-link … [Read more...] about Boston Scientific acquires Obsidio and its gel embolic material
Preceptis Medical wins FDA clearance for expanded indications of Hummingbird tympanostomy tube system
Preceptis Medical today announced its Hummingbird tympanostomy tube system (TTS) has received FDA 510(k) clearance for use in children six months and older. The Hummingbird TTS is used in office-based pediatric ear tube procedures. The Maple Grove, Minnesota-based company designed the system to allow ENTs to make an incision and deliver, … [Read more...] about Preceptis Medical wins FDA clearance for expanded indications of Hummingbird tympanostomy tube system
MedAlliance sirolimus-eluting balloon wins second FDA IDE
MedAlliance this week announced its Selution SLR sirolimus-eluting balloon received conditional FDA investigational device exemption (IDE) approval to begin a clinical trial for occlusive disease of the superficial femoral artery (SFA). The second IDE approval comes a few months after the Geneva, Switzerland-based company won IDE approval for … [Read more...] about MedAlliance sirolimus-eluting balloon wins second FDA IDE
BD issues Class I recall of some intraosseous needle set kits and drivers
BD (NYSE:BDX) has issued a class I recall of its intraosseous needle set kits for its intraosseous infusion system. BD issued the recall of its intraosseous needle set kits, manual driver kits and powered drivers due to three separate issues. The needle set kits stylets could be difficult to separate from the needle or not separate at all. The … [Read more...] about BD issues Class I recall of some intraosseous needle set kits and drivers
